{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:45:15Z","timestamp":1775483115636,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0523200"],"award-info":[{"award-number":["2024ZD0523200"]}]},{"name":"the National Natural Science Foundation of China Grant Awards","award":["82450002"],"award-info":[{"award-number":["82450002"]}]},{"name":"the National Natural Science Foundation of China Grant Awards","award":["82030026"],"award-info":[{"award-number":["82030026"]}]},{"name":"the National Natural Science Foundation of China Grant Awards","award":["82270883"],"award-info":[{"award-number":["82270883"]}]},{"name":"the National Natural Science Foundation of China Grant Awards","award":["82470866"],"award-info":[{"award-number":["82470866"]}]},{"name":"YLHR Diabetes Metabolism Research Fund Project of China International Medical Foundation","award":["Z-2017-26-2202-4"],"award-info":[{"award-number":["Z-2017-26-2202-4"]}]},{"name":"the Jiangsu Provincial Medical Key Discipline Cultivation Unit","award":["JSDW202201"],"award-info":[{"award-number":["JSDW202201"]}]},{"name":"the Natural Science Foundation of Jiangsu Province of China","award":["BK20241721"],"award-info":[{"award-number":["BK20241721"]}]},{"name":"the Nanjing Health Science and Technology Development Project","award":["ZKX24023"],"award-info":[{"award-number":["ZKX24023"]}]},{"name":"the Multidisciplinary Joint Innovation and Tackling New Technology Project from the Affiliated Drum Tower Hospital, Medical School of Nanjing University"},{"name":"the National Chinese-Western Medicine Clinical Collaboration Project for Major Difficult Diseases","award":["2024-92"],"award-info":[{"award-number":["2024-92"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02775-2","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:26:35Z","timestamp":1769844395000},"page":"947-957","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Henagliflozin enhances frontal neural activation and cognitive function versus gliclazide in type 2 diabetes patients with mild cognitive impairment: A 16-week randomized controlled trial"],"prefix":"10.1007","volume":"49","author":[{"given":"Yining","family":"Chao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuewei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2386-6141","authenticated-orcid":false,"given":"Zhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3914-7854","authenticated-orcid":false,"given":"Yan","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"2775_CR1","unstructured":"IDF Diabetes Atlas (2025) 11th Edition"},{"issue":"11","key":"2775_CR2","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1002\/alz.12482","volume":"17","author":"A Dove","year":"2021","unstructured":"Dove A, Shang Y, Xu W et al (2021) The impact of diabetes on cognitive impairment and its progression to dementia. Alzheimers Dement Nov 17(11):1769\u20131778. https:\/\/doi.org\/10.1002\/alz.12482","journal-title":"Alzheimers Dement Nov"},{"key":"2775_CR3","doi-asserted-by":"publisher","unstructured":"(2024) Alzheimer\u2019s disease facts and figures. Alzheimers Dement. May 2024;20(5):3708\u20133821. https:\/\/doi.org\/10.1002\/alz.13809","DOI":"10.1002\/alz.13809"},{"issue":"10","key":"2775_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels GJ, Despa F (2018) Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nature Reviews Endocrinology Oct 14(10):591\u2013604. https:\/\/doi.org\/10.1038\/s41574-018-0048-7","journal-title":"Nature Reviews Endocrinology Oct"},{"issue":"10452","key":"2775_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"10","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY et al (2024) Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. Lancet Aug 10(10452):572\u2013628. https:\/\/doi.org\/10.1016\/S0140-6736(24)01296-0","journal-title":"Lancet Aug"},{"issue":"9","key":"2775_CR6","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00592-023-02115-x","volume":"60","author":"C Berra","year":"2023","unstructured":"Berra C, Manfrini R, Mirani M et al (2023) AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus. Acta Diabetol 60(9):1257\u20131266. https:\/\/doi.org\/10.1007\/s00592-023-02115-x","journal-title":"Acta Diabetol"},{"key":"2775_CR7","doi-asserted-by":"publisher","unstructured":"Wang X, Huang W, Su L et al (2020) Neuroimaging advances regarding subjective cognitive decline in preclinical alzheimer\u2019s disease. Mol Neurodegeneration 15(1). https:\/\/doi.org\/10.1186\/s13024-020-00395-3","DOI":"10.1186\/s13024-020-00395-3"},{"issue":"9","key":"2775_CR8","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S1474-4422(11)70158-2","volume":"10","author":"M Pievani","year":"2011","unstructured":"Pievani M, de Haan W, Wu T, Seeley WW, Frisoni GB (2011) Functional network disruption in the degenerative dementias. Lancet Neurol Sep 10(9):829\u2013843. https:\/\/doi.org\/10.1016\/S1474-4422(11)70158-2","journal-title":"Lancet Neurol Sep"},{"key":"2775_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1109\/RBME.2018.2796598","volume":"11","author":"S Leandrou","year":"2018","unstructured":"Leandrou S, Petroudi S, Kyriacou PA, Reyes-Aldasoro CC, Pattichis CS (2018) Quantitative MRI brain studies in mild cognitive impairment and alzheimer\u2019s disease: A methodological review. IEEE Rev Biomed Eng 11:97\u2013111. https:\/\/doi.org\/10.1109\/RBME.2018.2796598","journal-title":"IEEE Rev Biomed Eng"},{"issue":"1","key":"2775_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/jamaneurol.2015.2952","volume":"73","author":"RO Roberts","year":"2016","unstructured":"Roberts RO, Christianson TJ, Kremers WK et al (2016) Association between olfactory dysfunction and amnestic mild cognitive impairment and alzheimer disease dementia. JAMA Neurol Jan 73(1):93\u2013101. https:\/\/doi.org\/10.1001\/jamaneurol.2015.2952","journal-title":"JAMA Neurol Jan"},{"key":"2775_CR11","doi-asserted-by":"publisher","first-page":"100956","DOI":"10.1016\/j.arr.2019.100956","volume":"55","author":"P Bathini","year":"2019","unstructured":"Bathini P, Brai E, Auber LA (2019) Olfactory dysfunction in the pathophysiological continuum of dementia. Ageing Res Rev Nov 55:100956. https:\/\/doi.org\/10.1016\/j.arr.2019.100956","journal-title":"Ageing Res Rev Nov"},{"issue":"4","key":"2775_CR12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/ana.21910","volume":"67","author":"SE Arnold","year":"2010","unstructured":"Arnold SE, Lee EB, Moberg PJ et al (2010) Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in alzheimer disease. Ann Neurol Apr 67(4):462\u2013469. https:\/\/doi.org\/10.1002\/ana.21910","journal-title":"Ann Neurol Apr"},{"issue":"2","key":"2775_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00001756-200102120-00021","volume":"12","author":"T Kovacs","year":"2001","unstructured":"Kovacs T, Cairns NJ, Lantos PL (2001) Olfactory centres in alzheimer\u2019s disease: olfactory bulb is involved in early braak\u2019s stages. Neuroreport Feb 12(2):285\u2013288. https:\/\/doi.org\/10.1097\/00001756-200102120-00021","journal-title":"Neuroreport Feb"},{"issue":"7","key":"2775_CR14","doi-asserted-by":"publisher","first-page":"e3673","DOI":"10.1002\/dmrr.3673","volume":"39","author":"S Tian","year":"2023","unstructured":"Tian S, Jiang J, Wang J et al (2023) Comparison on cognitive outcomes of antidiabetic agents for type 2 diabetes: A systematic review and network meta-analysis. Diabetes Metab Res Rev Oct 39(7):e3673. https:\/\/doi.org\/10.1002\/dmrr.3673","journal-title":"Diabetes Metab Res Rev Oct"},{"issue":"2","key":"2775_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2337\/dc22-1705","volume":"1","author":"CY Wu","year":"2023","unstructured":"Wu CY, Iskander C, Wang C et al (2023) Association of Sodium-Glucose cotransporter 2 inhibitors with time to dementia: A Population-Based cohort study. Diabetes Care Feb 1(2):297\u2013304. https:\/\/doi.org\/10.2337\/dc22-1705","journal-title":"Diabetes Care Feb"},{"key":"2775_CR16","doi-asserted-by":"publisher","first-page":"747620","DOI":"10.3389\/fcvm.2021.747620","volume":"8","author":"JV Mui","year":"2021","unstructured":"Mui JV, Zhou J, Lee S et al (2021) Sodium-Glucose cotransporter 2 (SGLT2) inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) inhibitors for New-Onset dementia: A propensity Score-Matched Population-Based study with competing risk analysis. Front Cardiovasc Med 8:747620. https:\/\/doi.org\/10.3389\/fcvm.2021.747620","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"2775_CR17","doi-asserted-by":"publisher","first-page":"147916412210981","DOI":"10.1177\/14791641221098168","volume":"19","author":"WZ Siao","year":"2022","unstructured":"Siao WZ, Lin TK, Huang JY, Tsai CF, Jong GP (2022) The association between sodium-glucose cotransporter 2 inhibitors and incident dementia: A nationwide population-based longitudinal cohort study. Diab Vasc Dis Res May-Jun 19(3):14791641221098168. https:\/\/doi.org\/10.1177\/14791641221098168","journal-title":"Diab Vasc Dis Res May-Jun"},{"key":"2775_CR18","doi-asserted-by":"publisher","first-page":"e079475","DOI":"10.1136\/bmj-2024-079475","volume":"386","author":"A Shin","year":"2024","unstructured":"Shin A, Koo BK, Lee JY, Kang EH (2024) Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40\u201369 years with type 2 diabetes: population based cohort study. BMJ Aug 28 386:e079475. https:\/\/doi.org\/10.1136\/bmj-2024-079475","journal-title":"BMJ Aug 28"},{"issue":"5","key":"2775_CR19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1001\/jamaneurol.2025.0353","volume":"1","author":"H Tang","year":"2025","unstructured":"Tang H, Donahoo WT, DeKosky ST et al (2025) GLP-1RA and SGLT2i medications for type 2 diabetes and alzheimer disease and related dementias. JAMA Neurol May 1(5):439\u2013449. https:\/\/doi.org\/10.1001\/jamaneurol.2025.0353","journal-title":"JAMA Neurol"},{"issue":"2","key":"2775_CR20","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3233\/JAD-215678","volume":"87","author":"S Low","year":"2022","unstructured":"Low S, Goh KS, Ng TP et al (2022) Association between use of Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitors and cognitive function in a longitudinal study of patients with type 2 diabetes. J Alzheimers Dis 87(2):635\u2013642. https:\/\/doi.org\/10.3233\/JAD-215678","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"2775_CR21","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/jdi.14306","volume":"15","author":"S Zhang","year":"2024","unstructured":"Zhang S, Wang F, Xie L et al (2024) Sodium-glucose cotransporter 2 Inhibition through Henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes. J Diabetes Investig Nov 15(11):1596\u20131603. https:\/\/doi.org\/10.1111\/jdi.14306","journal-title":"J Diabetes Investig Nov"},{"key":"2775_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2147\/CPAA.S164785","volume":"10","author":"S Perna","year":"2018","unstructured":"Perna S, Mainardi M, Astrone P et al (2018) 12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus. Clin Pharmacol 10:141\u2013151. https:\/\/doi.org\/10.2147\/CPAA.S164785","journal-title":"Clin Pharmacol"},{"issue":"5","key":"2775_CR23","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.2337\/dc21-2064","volume":"1","author":"H Cheng","year":"2022","unstructured":"Cheng H, Zhang Z, Zhang B et al (2022) Enhancement of impaired olfactory neural activation and cognitive capacity by Liraglutide, but not Dapagliflozin or Acarbose, in patients with type 2 diabetes: A 16-Week randomized parallel comparative study. Diabetes Care May 1(5):1201\u20131210. https:\/\/doi.org\/10.2337\/dc21-2064","journal-title":"Diabetes Care May"},{"issue":"6","key":"2775_CR24","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s00125-021-05393-8","volume":"64","author":"GJ Biessels","year":"2021","unstructured":"Biessels GJ, Verhagen C, Janssen J et al (2021) Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study. Diabetologia Jun 64(6):1235\u20131245. https:\/\/doi.org\/10.1007\/s00125-021-05393-8","journal-title":"Diabetologia Jun"},{"issue":"5","key":"2775_CR25","doi-asserted-by":"publisher","first-page":"994","DOI":"10.2337\/db17-1274","volume":"67","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Zhang B, Wang X et al (2018) Altered Odor-Induced brain activity as an early manifestation of cognitive decline in patients with type 2 diabetes. Diabetes May 67(5):994\u20131006. https:\/\/doi.org\/10.2337\/db17-1274","journal-title":"Diabetes May"},{"issue":"7","key":"2775_CR26","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.2337\/dc18-2584","volume":"42","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang B, Wang X et al (2019) Olfactory dysfunction mediates adiposity in cognitive impairment of type 2 diabetes: insights from clinical and functional neuroimaging studies. Diabetes Care Jul 42(7):1274\u20131283. https:\/\/doi.org\/10.2337\/dc18-2584","journal-title":"Diabetes Care Jul"},{"issue":"3","key":"2775_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12021-016-9299-4","volume":"14","author":"CG Yan","year":"2016","unstructured":"Yan CG, Wang XD, Zuo XN, Zang YF (2016) DPABI: data processing & analysis for (Resting-State). Brain Imaging Neuroinformatics Jul 14(3):339\u2013351. https:\/\/doi.org\/10.1007\/s12021-016-9299-4","journal-title":"Brain Imaging Neuroinformatics Jul"},{"issue":"4","key":"2775_CR28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/hbm.460020402","volume":"2","author":"KJ Friston","year":"1994","unstructured":"Friston KJ, Holmes AP, Worsley KJ, Poline J-P, Frith CD, Frackowiak RSJ (1994) Statistical parametric maps in functional imaging: A general linear approach. Hum Brain Mapp 2(4):189\u2013210. https:\/\/doi.org\/10.1002\/hbm.460020402","journal-title":"Hum Brain Mapp"},{"issue":"8","key":"2775_CR29","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S1474-4422(20)30139-3","volume":"19","author":"GJ Biessels","year":"2020","unstructured":"Biessels GJ, Nobili F, Teunissen CE, Simo R, Scheltens P (2020) Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective. Lancet Neurol Aug 19(8):699\u2013710. https:\/\/doi.org\/10.1016\/S1474-4422(20)30139-3","journal-title":"Lancet Neurol Aug"},{"issue":"42","key":"2775_CR30","doi-asserted-by":"publisher","first-page":"e2219666120","DOI":"10.1073\/pnas.2219666120","volume":"17","author":"KG Schilling","year":"2023","unstructured":"Schilling KG, Li M, Rheault F et al (2023) Whole-brain, gray, and white matter time-locked functional signal changes with simple tasks and model-free analysis. Proc Natl Acad Sci U S A Oct 17(42):e2219666120. https:\/\/doi.org\/10.1073\/pnas.2219666120","journal-title":"Proc Natl Acad Sci U S A Oct"},{"issue":"1","key":"2775_CR31","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1038\/s41467-023-39067-3","volume":"9","author":"Y Huang","year":"2023","unstructured":"Huang Y, Wei PH, Xu L et al (2023) Intracranial electrophysiological and structural basis of BOLD functional connectivity in human brain white matter. Nat Commun Jun 9(1):3414. https:\/\/doi.org\/10.1038\/s41467-023-39067-3","journal-title":"Nat Commun Jun"},{"issue":"7","key":"2775_CR32","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1002\/alz.13040","volume":"19","author":"N Islam","year":"2023","unstructured":"Islam N, Hashem R, Gad M et al (2023) Accuracy of the Montreal cognitive assessment tool for detecting mild cognitive impairment: A systematic review and meta-analysis. Alzheimers Dement Jul 19(7):3235\u20133243. https:\/\/doi.org\/10.1002\/alz.13040","journal-title":"Alzheimers Dement Jul"},{"key":"2775_CR33","doi-asserted-by":"publisher","first-page":"106396","DOI":"10.1016\/j.phrs.2022.106396","volume":"183","author":"ME Lunati","year":"2022","unstructured":"Lunati ME, Cimino V, Gandolfi A et al (2022) SGLT2-inhibitors are effective and safe in the elderly: the SOLD study. Pharmacol Res Sep 183:106396. https:\/\/doi.org\/10.1016\/j.phrs.2022.106396","journal-title":"Pharmacol Res Sep"},{"issue":"3","key":"2775_CR34","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/dom.15376","volume":"26","author":"C Yu","year":"2024","unstructured":"Yu C, Wang Y, Zhang B et al (2024) Associations between complexity of glucose time series and cognitive function in adults with type 2 diabetes. Diabetes Obes Metab Mar 26(3):840\u2013850. https:\/\/doi.org\/10.1111\/dom.15376","journal-title":"Diabetes Obes Metab Mar"},{"key":"2775_CR35","doi-asserted-by":"publisher","unstructured":"Miao Y, Zhang B, Sun X et al (2023) The presence and severity of NAFLD are associated with cognitive impairment and hippocampal damage. J Clin Endocrinol Metab 13. https:\/\/doi.org\/10.1210\/clinem\/dgad352","DOI":"10.1210\/clinem\/dgad352"},{"issue":"12","key":"2775_CR36","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1007\/s40618-023-02162-9","volume":"46","author":"G Bendotti","year":"2023","unstructured":"Bendotti G, Montefusco L, Pastore I, Lazzaroni E, Lunati ME, Fiorina P (2023) The anti-inflammatory and immunological properties of SGLT-2 inhibitors. J Endocrinol Investig 46(12):2445\u20132452 https:\/\/doi.org\/10.1007\/s40618-023-02162-9","journal-title":"J Endocrinol Investig"},{"key":"2775_CR37","doi-asserted-by":"publisher","first-page":"106062","DOI":"10.1016\/j.phrs.2022.106062","volume":"176","author":"MR Rizzo","year":"2022","unstructured":"Rizzo MR, Di Meo I, Polito R et al (2022) Cognitive impairment and type 2 diabetes mellitus: focus of SGLT2 inhibitors treatment. Pharmacol Res Feb 176:106062. https:\/\/doi.org\/10.1016\/j.phrs.2022.106062","journal-title":"Pharmacol Res Feb"},{"key":"2775_CR38","doi-asserted-by":"publisher","unstructured":"Pawlos A, Broncel M, Wozniak E, Gorzelak-Pabis P (2021) Neuroprotective effect of SGLT2 inhibitors. Molecules Nov 28(23). https:\/\/doi.org\/10.3390\/molecules26237213","DOI":"10.3390\/molecules26237213"},{"key":"2775_CR39","doi-asserted-by":"publisher","first-page":"107517","DOI":"10.1016\/j.phrs.2024.107517","volume":"210","author":"C Berra","year":"2024","unstructured":"Berra C, Manfrini R, Bifari F et al (2024) Improved glycemic and weight control with dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE-2 study. Pharmacol Res 210:107517. https:\/\/doi.org\/10.1016\/j.phrs.2024.107517","journal-title":"Pharmacol Res"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02775-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02775-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02775-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:47:31Z","timestamp":1775479651000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02775-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["2775"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02775-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}